Stephen L. Yates

1.0k total citations
30 papers, 838 citations indexed

About

Stephen L. Yates is a scholar working on Molecular Biology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, Stephen L. Yates has authored 30 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 9 papers in Psychiatry and Mental health. Recurrent topics in Stephen L. Yates's work include Mast cells and histamine (9 papers), Epilepsy research and treatment (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Stephen L. Yates is often cited by papers focused on Mast cells and histamine (9 papers), Epilepsy research and treatment (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Stephen L. Yates collaborates with scholars based in United States, Germany and Belgium. Stephen L. Yates's co-authors include Clark E. Tedford, James G. Phillips, Kurt R. Brunden, Eric Fluhler, Simon Borghs, Joyce Antal, Loyd H. Burgess, Syed Mashhood Ali, Toufic Fakhoury and Klaus Eckhardt and has published in prestigious journals such as Neurology, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Stephen L. Yates

30 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen L. Yates United States 16 310 254 216 216 216 30 838
Makoto Ohgoh Japan 11 231 0.7× 233 0.9× 366 1.7× 162 0.8× 48 0.2× 16 668
Elena Meli Italy 15 353 1.1× 77 0.3× 380 1.8× 30 0.1× 59 0.3× 20 955
Kimberly J. Jenko United States 16 431 1.4× 255 1.0× 299 1.4× 74 0.3× 91 0.4× 26 1.4k
Rena Li United States 13 256 0.8× 130 0.5× 164 0.8× 47 0.2× 60 0.3× 20 1.0k
Shiro Hariguchi Japan 16 317 1.0× 66 0.3× 140 0.6× 17 0.1× 73 0.3× 27 758
Doru Georg Margineanu Belgium 21 431 1.4× 846 3.3× 869 4.0× 491 2.3× 22 0.1× 32 1.3k
Susan A. Borosky United States 12 479 1.5× 125 0.5× 552 2.6× 48 0.2× 28 0.1× 16 988
Cristian Salinas United Kingdom 17 394 1.3× 136 0.5× 346 1.6× 34 0.2× 47 0.2× 40 1.0k
I.J.M. Beresford United Kingdom 19 627 2.0× 239 0.9× 743 3.4× 30 0.1× 100 0.5× 36 1.3k

Countries citing papers authored by Stephen L. Yates

Since Specialization
Citations

This map shows the geographic impact of Stephen L. Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Yates more than expected).

Fields of papers citing papers by Stephen L. Yates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Yates. The network helps show where Stephen L. Yates may publish in the future.

Co-authorship network of co-authors of Stephen L. Yates

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Yates. A scholar is included among the top collaborators of Stephen L. Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Yates. Stephen L. Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manning, Elizabeth J. B., et al.. (2020). Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies. Therapeutic Innovation & Regulatory Science. 54(5). 1001–1009. 2 indexed citations
2.
Arnold, Stephan, et al.. (2020). Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial. Epilepsy Research. 166. 106404–106404. 5 indexed citations
3.
Wechsler, Robert, et al.. (2016). Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension. Epilepsy Research. 130. 13–20. 31 indexed citations
4.
Yates, Stephen L., Toufic Fakhoury, Wei Liang, et al.. (2015). An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam. Epilepsy & Behavior. 52(Pt A). 165–168. 121 indexed citations
5.
Guptill, Jeffrey T., et al.. (2014). Assessment of the effects of lacosamide on sleep parameters in healthy subjects. Seizure. 25. 155–159. 11 indexed citations
6.
Szaflarski, Jerzy P., et al.. (2008). Seizure control in patients with epilepsy: the physician vs. medication factors. BMC Health Services Research. 8(1). 264–264. 30 indexed citations
7.
Szaflarski, Jerzy P., et al.. (2007). Levetiracetam use in critically ill patients. Neurocritical Care. 7(2). 140–147. 45 indexed citations
8.
Brunden, Kurt R., et al.. (2003). Aβ-Induced Proinflammatory Cytokine Release from Differentiated Human THP-1 Monocytes. Humana Press eBooks. 32. 101–112. 1 indexed citations
9.
Yates, Stephen L., et al.. (2000). Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia. Journal of Neurochemistry. 74(3). 1017–1025. 178 indexed citations
10.
Yates, Stephen L., et al.. (1999). Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex. Biochemical Pharmacology. 57(9). 1059–1066. 16 indexed citations
11.
Yates, Stephen L., et al.. (1999). [46] Inflammatory responses to amyloid fibrils. Methods in enzymology on CD-ROM/Methods in enzymology. 309. 723–733. 7 indexed citations
12.
Ali, Syed Mashhood, et al.. (1999). Design, Synthesis, and Structure−Activity Relationships of Acetylene-Based Histamine H3 Receptor Antagonists. Journal of Medicinal Chemistry. 42(5). 903–909. 50 indexed citations
13.
Yates, Stephen L., et al.. (1999). Identification and Pharmacological Characterization of a Series of New 1 H-4-Substituted-Imidazoyl Histamine H3 Receptor Ligands. Journal of Pharmacology and Experimental Therapeutics. 289(2). 1151–1159. 23 indexed citations
14.
Tedford, Clark E., et al.. (1998). Pharmacological characterization of GT-2331, a new CNS-penetrating high affinity histamine H3 receptor antagonist. The Society for Neuroscience Abstracts. 24. 1838. 1 indexed citations
15.
Tedford, Clark E., Marcel Hoffmann, Nahid Seyedi, et al.. (1998). High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models. European Journal of Pharmacology. 351(3). 307–311. 41 indexed citations
16.
Yates, Stephen L., et al.. (1995). Up-regulation of nicotinic acetylcholine receptors following chronic exposure of rats to mainstream cigarette smoke or α4β2 receptors to nicotine. Biochemical Pharmacology. 50(12). 2001–2008. 57 indexed citations
17.
Yates, Stephen L., Eric Fluhler, & P M Lippiello. (1992). Advances in the use of the fluorescent probe fura‐2 for the estimation of intrasynatposomal calcium. Journal of Neuroscience Research. 32(2). 255–260. 29 indexed citations
18.
Yates, Stephen L., et al.. (1990). Inhibitory effect of EDTA · Ca2+ on the hydrolysis of synaptosomal phospholipids by phospholipase A2 toxins and enzymes. Biochemical Pharmacology. 40(10). 2233–2239. 14 indexed citations
19.
Yates, Stephen L., Lawrence Levine, & P. Rosenberg. (1990). Leukotriene and prostaglandin production in rat brain synaptosomes treated with phospholipase A2 neurotoxins and enzymes. Prostaglandins. 39(4). 425–438. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Ohgoh Breakdown of academic impact, for papers by Elena Meli Breakdown of academic impact, for papers by Kimberly J. Jenko Breakdown of academic impact, for papers by Rena Li Breakdown of academic impact, for papers by Shiro Hariguchi Breakdown of academic impact, for papers by Doru Georg Margineanu Breakdown of academic impact, for papers by Susan A. Borosky Breakdown of academic impact, for papers by Cristian Salinas Breakdown of academic impact, for papers by I.J.M. Beresford
Rankless by CCL
2026